A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
A Randomized Trial of Two Saquinavir-Containing Combination Treatment Regimens in Children With HIV Infection
The purpose of this study is to determine the safety and effectiveness of a soft-gel capsule formulation of saquinavir (SQV-SGC), a protease inhibitor, when given in combination with other anti-HIV drugs.
SQV-SGC has been tested in adults for the treatment of HIV infection, but more information is still needed about SQV-SGC in children. Recent studies suggest that this soft-gel capsule form may be safer and more effective than other protease inhibitors.
調査の概要
詳細な説明
Clinical trials in adults and children suggest that SQV-SGC has advantages over other protease inhibitors in terms of tolerability, safety, and effectiveness in patients who have failed therapy with other protease inhibitors. [AS PER AMENDMENT 11/24/99: Pharmacokinetic data from this study demonstrate lower than expected plasma SQV exposures, particularly in Arm 1. Based on these data, patients in the study will be offered the opportunity to adjust their doses. Ritonavir added to the Arm 1 regimen is expected to significantly increase SQV-SGC plasma levels and allow twice-daily dosing for SQV-SGC.]
Patients are randomized to one of two study arms. Patients in Arm 1 receive SQV-SGC plus two [AS PER AMENDMENT 11/24/99: one or two] NRTIs of choice. Patients in Arm 2 receive SQV-SGC plus NFV plus one or two NRTIs of choice. All participants are evaluated by physical examinations and laboratory tests during the study and are followed for incidence of death, cancer, or fetal abnormality. NRTIs are not provided as part of this study. [AS PER AMENDMENT 11/24/99: This study is closed to accrual. All subjects on follow-up (Cohort 1) are given the option of either discontinuing participation in ACTG 397 or participating in the next phase of the study (version 2.0). Those electing to continue participation constitute Cohort 1A. The adjusted Arm 1 regimen consists of SQV-SGC plus ritonavir plus one or two NRTIs. Ritonavir is not provided as part of this study. The Arm 2 regimen study drugs have not changed but the maximum allowable dose of SQV-SGC has increased from 1,200 mg twice-daily to 1,600 mg twice-daily. Participants continue to be followed with physical examinations and laboratory evaluations that include an intensive pharmacokinetics study on Day 14 of the new regimen.]
研究の種類
入学
段階
- フェーズ2
連絡先と場所
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35233
- Univ of Alabama at Birmingham - Pediatric
-
Birmingham、Alabama、アメリカ、352330011
- Univ of Alabama at Birmingham / Childrens Hosp of AL
-
-
California
-
Long Beach、California、アメリカ、90801
- Long Beach Memorial (Pediatric)
-
Los Angeles、California、アメリカ、90033
- Los Angeles County - USC Med Ctr
-
Oakland、California、アメリカ、946091809
- Children's Hosp of Oakland
-
San Francisco、California、アメリカ、941430105
- UCSF / Moffitt Hosp - Pediatric
-
-
Connecticut
-
New Haven、Connecticut、アメリカ、06504
- Yale Univ Med School
-
-
District of Columbia
-
Washington、District of Columbia、アメリカ、20060
- Howard Univ Hosp
-
-
Florida
-
Miami、Florida、アメリカ、33161
- Univ of Miami (Pediatric)
-
Riviera Beach、Florida、アメリカ、33404
- Palm Beach County Health Dept
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30306
- Emory Univ Hosp / Pediatrics
-
-
Illinois
-
Chicago、Illinois、アメリカ、60612
- Cook County Hosp
-
Chicago、Illinois、アメリカ、606143394
- Chicago Children's Memorial Hosp
-
Chicago、Illinois、アメリカ、60612
- Univ of Illinois College of Medicine / Pediatrics
-
-
Louisiana
-
New Orleans、Louisiana、アメリカ、701122699
- Tulane Univ / Charity Hosp of New Orleans
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21201
- Univ of Maryland at Baltimore / Univ Med Ctr
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、021155724
- Children's Hosp of Boston
-
Springfield、Massachusetts、アメリカ、01199
- Baystate Med Ctr of Springfield
-
-
Mississippi
-
Jackson、Mississippi、アメリカ、39213
- Univ of Mississippi Med Ctr
-
-
New Jersey
-
Newark、New Jersey、アメリカ、071032714
- Univ of Medicine & Dentistry of New Jersey / Univ Hosp
-
-
New York
-
Albany、New York、アメリカ、12208
- Children's Hosp at Albany Med Ctr
-
Bronx、New York、アメリカ、10461
- Bronx Municipal Hosp Ctr/Jacobi Med Ctr
-
Bronx、New York、アメリカ、10457
- Bronx Lebanon Hosp Ctr
-
Great Neck、New York、アメリカ、11021
- North Shore Univ Hosp
-
New York、New York、アメリカ、10021
- Cornell Univ Med College
-
New York、New York、アメリカ、10032
- Columbia Presbyterian Med Ctr
-
New York、New York、アメリカ、10032
- Incarnation Children's Ctr / Columbia Presbyterian Med Ctr
-
New York、New York、アメリカ、10037
- Harlem Hosp Ctr
-
Stony Brook、New York、アメリカ、117948111
- State Univ of New York at Stony Brook
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、アメリカ、191341095
- Saint Christopher's Hosp for Children
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、294253312
- Med Univ of South Carolina
-
-
Virginia
-
Richmond、Virginia、アメリカ、23219
- Med College of Virginia
-
-
Washington
-
Seattle、Washington、アメリカ、981050371
- Children's Hospital & Medical Center / Seattle ACTU
-
-
-
-
-
Bayamon、プエルトリコ、00956
- Ramon Ruiz Arnau Univ Hosp / Pediatrics
-
San Juan、プエルトリコ、009367344
- San Juan City Hosp
-
San Juan、プエルトリコ、009365067
- Univ of Puerto Rico / Univ Children's Hosp AIDS
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria
Your child may be eligible for this study if he or she:
- Is HIV-positive.
- Is 3 to 16 years of age (consent of parent or guardian is required).
- Has an HIV level greater than 10,000 copies/ml.
- Has never taken at least one of the following anti-HIV drugs: lamivudine, zidovudine, stavudine, or didanosine.
- Is able to swallow capsules and tablets.
Exclusion Criteria
Your child will not be eligible if he or she:
- Has cancer requiring chemotherapy.
- Has an acute opportunistic (AIDS-related) infection requiring therapy.
- Has had two or more episodes of moderate or severe diarrhea or vomiting in the 3 months prior to study entry.
- Has ever taken SQV or NFV.
- Is pregnant or breast-feeding.
- Is taking certain medications, including those that would interfere with the study drugs.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
協力者と研究者
捜査官
- スタディチェア:Courtney Fletcher
- スタディチェア:Mark Kline
出版物と役立つリンク
一般刊行物
- Brundage RC, Kline MW, Lindsey J, Fenton T, Fletcher CV. Pharmacokinetics of saquinavir (SQV) with nelfinavir (NFV) or ritonavir (RTV) in HIV-infected children. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 728)
- Kline MW, Fletcher CV, Lindsey JC, Fenton T. A randomized trial of two saquinavir (SQV-SGC)-containing combination treatment regimens in HIV-infected children. 7th Conference on Retroviruses and Opportunistic Infections. 2000 Jan 30-Feb 2 [Poster 694]
- Kline MW, Fletcher CV, Lindsey JC, Fenton T. A randomized trial of combination therapy with saquinavir soft gelatin capsules (SQV) in HIV-infected children. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 683)
- Brundage RC, Kline MW, Lindsey JC, Fenton T, Fletcher CV. Pharmacokinetics (PK) of saquinavir (SQV) and nelfinavir (NFV) in a twice-daily (BID) regimen in HIV-infected children. 7th Conference on Retroviruses and Opportunistic Infections. 2000 Jan 30-Feb 2 [Poster 718]
研究記録日
主要日程の研究
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- ACTG 397
- 11353 (レジストリ識別子:DAIDS ES)
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
HIV感染症の臨床試験
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public Health募集HIV | HIV検査 | HIV とケアの関係 | HIV治療アメリカ
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS Foundation完了パートナーの HIV 検査 | カップルの HIV カウンセリング | カップルのコミュニケーション | HIV の発生率カメルーン, ドミニカ共和国, グルジア, インド
-
University of Minnesota引きこもったHIV感染症 | HIV/エイズ | HIV | AIDS | エイズ・HIV問題 | エイズと感染症アメリカ
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University of Southampton と他の協力者募集
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement; Centre Pasteur... と他の協力者わからないHIV | HIVに感染していない子供たち | HIVにさらされた子供たちカメルーン
-
Erasmus Medical Centerまだ募集していません
-
University of Maryland, Baltimore引きこもった
-
Hospital Clinic of Barcelona完了
-
University of WashingtonNational Institute of Mental Health (NIMH)募集
リトナビルの臨床試験
-
Shandong Provincial HospitalGansu Provincial Hospital; The Affiliated Hospital Of Southwest Medical University; Rizhao People... と他の協力者募集
-
First People's Hospital of HangzhouHangzhou Cancer Hospital; First People's Hospital of Lin'an District; First People's Hospital...募集
-
AbbVie完了慢性C型肝炎 | C型肝炎(HCV) | C型肝炎遺伝子型1a
-
Jiangsu Simcere Pharmaceutical Co., Ltd.完了
-
Genuine Research Center, EgyptEva Pharma完了